In a DDW Daily News video exclusive, DDW Council Chair Grace H. Elta, MD, AGAF, FASGE, discusses four notable abstracts from DDW 2018 in Washington, D.C. Dr. Elta highlights one abstract from each of the four DDW-sponsoring societies.
Although antiviral therapy has led to a cure rate of more than 90 percent of hepatitis C virus (HCV) cases, David E. Bernstein, MD, FAASLD, thinks more can be done to increase the cure rate. In this DDW Daily News video exclusive, Dr. Bernstein discusses several obstacles preventing patients’ access to curative therapies. He also addresses the benefits of HCV therapy and whether it’s possible to eradicate HCV and achieve 100 percent cure rate.
During the SSAT Presidential Plenary on Sunday, SSAT President Stanley W. Ashley, MD, said the society is preparing for a new strategic plan that will re-evaluate the society’s role as well as its financial future and ongoing relationship with DDW®. “We are at the right time to start planning the next 10 years,” he said.
It has long been clear that “we are what we eat.” But a growing body of experimental data suggests it is not just what we eat, but how our individual gut microbiomes interact with diet that affects health. Federico Rey, PhD, explained this data during an AGA Symposium on Sunday.
Suresh Chari, MD, examined the medical and nutritional therapies for pain management in an ASGE Clinical Symposium on Sunday morning. “Pain is processed in some of the same areas of the brain as thoughts and emotions — structural damage or inflammation are not essential to experience pain,” Dr. Chari said.
Whether you have an evening free after DDW® sessions or you’re staying a couple extra days after the meeting, Washington, D.C., offers a variety of activities and capital sights to see this spring.
Patrick S. Kamath, MD, DM, MBBS, will define acute-on-chronic liver failure and review its history and scope during Monday’s AASLD State-of-the-Art Lecture Acute on Chronic Liver Failure: Pathophysiology and Therapeutic Approach.
Gastroenterologists can play an important role in the opioid epidemic, according to Eva Szigethy, MD, PhD. She weighs in on how GIs can help their patients as she previews Monday’s AGA Clinical Symposium Impact of America’s Opioid Epidemic on the Practice of Gastroenterology.
Grace H. Elta, MD, AGAF, FASGE, will co-moderate Monday’s ASGE Clinical Symposium Pancreatic Duct Endotherapy: Caution or Full Steam Ahead, which will review the current science and best practices for endotherapy in pancreatitis treatment.
Kathleen E. Corey, MD, MPH, MMSc, will deliver “Challenges in Screening for NAFLD (Including At-Risk Populations)” during Clinical Challenges in Adult and Pediatric Non-Alcoholic Fatty Liver Disease on Monday.
